Evidence map›Paper›PMID 24305066›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2014

Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).

Valentina Sancisi, Elena Germinario, Alessandra Esposito, Elisabetta Morini, Samantha Peron, Maurizio Moggio, Giuliano Tomelleri, Daniela Danieli-Betto, Rossella Tupler

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Influence of ageing and essential amino acids on quantitative patterns of troponin T alternative splicing in human skeletal muscle.Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2015
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Valentina SancisiDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy;
Elena Germinario
Alessandra Esposito
Elisabetta Morini
Samantha Peron
Maurizio Moggio
Giuliano Tomelleri
Daniela Danieli-Betto
Rossella Tupler
University of Padua · ITUniversity of Modena and Reggio Emilia · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Massachusetts Chan Medical School · USUniversity of Verona · IT

Funding

TRAINING GRANT IN GENETICST32GM007748 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Anne O'Donnell-Luria, Louise Wilkins-Haug · 1985 to 2026
$12.0M
Investigating the Molecular Basis of FSHDR01NS047584 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TUPLER, ROSSELLA G · 2003 to 2007
$1.8M
An Animal model to develop therapeutic strategies for FSHDR01AR056129 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TUPLER, ROSSELLA G · 2007 to 2011
$1.7M
NIAMS NIH HHS 5R01AR056129NIGMS NIH HHS T32 GM007748NINDS NIH HHS R01NS047584Telethon GTB12001
6 · The paper itself

Abstract

Facioscapulohumeral muscular dystrophy (FSHD), a common hereditary myopathy, is characterized by atrophy and weakness of selective muscle groups. FSHD is considered an autosomal dominant disease with incomplete penetrance and unpredictable variability of clinical expression within families. Mice overexpressing FRG1 (FSHD region gene 1), a candidate gene for this disease, develop a progressive myopathy with features of the human disorder. Here, we show that in FRG1-overexpressing mice, fast muscles, which are the most affected by the dystrophic process, display anomalous fast skeletal troponin T (fTnT) isoform, resulting from the aberrant splicing of the Tnnt3 mRNA that precedes the appearance of dystrophic signs. We determine that muscles of FRG1 mice develop less strength due to impaired contractile properties of fast-twitch fibers associated with an anomalous MyHC-actin ratio and a reduced sensitivity to Ca(2+). We demonstrate that the decrease of Ca(2+) sensitivity of fast-twitch fibers depends on the anomalous troponin complex and can be rescued by the substitution with the wild-type proteins. Finally, we find that the presence of aberrant splicing isoforms of TNNT3 characterizes dystrophic muscles in FSHD patients. Collectively, our results suggest that anomalous TNNT3 profile correlates with the muscle impairment in both humans and mice. On the basis of these results, we propose that aberrant fTnT represents a biological marker of muscle phenotype severity and disease progression.

Indexed as

Alternative SplicingAnimalsBiomarkersGene Expression RegulationMiceMice, TransgenicMicrofilament ProteinsMuscle Fibers, Fast-TwitchMuscle WeaknessProteinsRNA-Binding ProteinsRNA, MessengerTroponin TBiomarkersFrg1 protein, mouseMicrofilament ProteinsProteinsRNA-Binding ProteinsRNA, MessengerTroponin Taberrant splicingFRG1muscle weaknessmuscular dystrophytroponin T

Identifiers

PMID24305066
PMCPMC3921317
OpenAlexW2124202405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.